The Promise and Potential of CAR T-Cell Therapy in Rheumatology: Emerging Evidence and Key Insights for Real-World Integration and Patient Care

Go Back
icon pur peopl

Join our upcoming webinar to explore the transformative potential of CAR T-cell therapy in rheumatology!   

Originally developed for hematologic cancers, this cutting-edge treatment is now being investigated for autoimmune diseases like systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and idiopathic inflammatory myopathies (IIM) – showing promise in achieving durable, drug-free remission in patients with severe disease who have not responded to existing therapies. 

With new clinical trials and emerging data, this session will provide expert insights into the evolving evidence, practical considerations for patient selection, and interprofessional strategies to address the challenges of cost, complexity, and equitable access. 

Don’t miss this opportunity to hear directly from leading experts who have pioneered the study and application of CAR T-cell therapy in real-world settings so you can stay ahead of the curve in integrating this groundbreaking technology into rheumatology care. 

Plus, you can earn 1.5 CME/MOC! Register now for FREE.  


How To Participate 

This is a virtual event, so please register following these 3 easy steps:

  1. Go to our registration page and register for the Summit.
  2. Save your registration email with your link and login information.
  3. Log in to the virtual meeting app during the Summit to participate!

The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!


Please note: you must register and complete the poll/survey questions in the virtual meeting app to claim your free CME credits.


Watch Party Locations - Check back for updates in your
area as more locations are confirmed
  Join a Local Watch Party to network with your colleagues and enjoy a memorable meal while watching the presentations. More locations will be added over time; you can register now as a virtual attendee and modify your registration to pick a Watch Party later.
- Arkansas
- Atlanta, GA
- Boston, MA
- Central Valley (Visalia), CA
- Jacksonville, FL
- Lewisburg, PA
- Palo Alto, CA
- Pittsburg, PA
- San Diego, CA		 - Tampa, FL
- Toronto, Ontario, Canada
- Tulsa, OK
- Vancouver, British Columbia, Canada
- Washington, D.C.
- Milwaukee, WI



Summit Details
1

Date: February 8th, 2025

Time: 12:00 PM – 15:20 EST
1


Location: Virtual with Community Locations
icon pur peopl

Chairs:

  • Grace C. Wright, MD, PhD, FACR
    AWIR President and Founder
  • Priya Reddy, MD, FACR
    AWIR Secretary and Treasurer
User Image - Dr.Wright User Image -Priya Reddy
icon pur peopl

Speakers

    User Image - David Porter
  • David L. Porter, MD
    Jodi Fisher Horowitz Professor of Leukemia Care Excellence
    Director, Center for Cell Therapy and Transplant
    University of Pennsylvania
    • User Image -Peter A. Merkel
  • Peter A. Merkel, MD, MPH 
    Chief, Division of Rheumatology
    Professor of Medicine and Epidemiology
    University of Pennsylvania


Program (EST)

12:00-12:10 - Welcome Remarks

12:10-12:40  - Product Theater

                          "BIMZELX® (bimekizumab-bkzx): Expert Perspectives on A New 

                           Treatment for PsA, NR-AxSpA, and AS" 

                           User Image -Dr-Ara-Dikranian.png 

                            • Presented by Dr. Ara Dikranian

                            • Sponsored by UCB

  
12:40-14:10 - Accredited Session

                         “The Promise and Potential of CAR T-Cell Therapy in Rheumatology: 

                          Emerging Evidence and Key Insights for Real-World Integration and 

                          Patient Care”

                            • Presented by Drs. David Porter and Peter Merkel

                            • 1.5 CME/MOC 


14:10-14:25 - Break


14:25-14:55 - Product Theater

                         “Ready for Change – Considering MOA Switching to Help Patients 

                          Achieve Remission in the Treatment of RA”

                            • Presented by Dr. Gordon Lam

                            • Sponsored by AbbVie

14:55-15:05 - Closing Remarks

CME Session Information

Learning Objectives:

  • Describe the principles, mechanisms, and administration of new and emerging CAR T-cell therapies.
  • Evaluate the latest clinical safety and efficacy data on emerging CAR T-cell therapies for the treatment of rheumatic conditions. 
  • Apply patient factors and disease characteristics to identify patients with rheumatic diseases who would benefit from CAR T-cell therapy.
  • Incorporate interprofessional strategies for optimal access to, administration of, and monitoring of CAR T-cell therapies in patients with rheumatic diseases.  
icon pur peopl

Agenda: 

  • Overview of CAR T-Cell Therapy: Principles, Mechanisms, and Administration
  • Current Use of CAR T-Cell Therapy: Evidence and Experience in Hematology & Oncology
  • Application of CAR T-Cell Therapy in Rheumatology: Clinical Trials and Early Data
  • Integration of CAR T-Cell Therapy in Rheumatology: Patient Diversity and Eligibility, System and Team Resources, and Equitable Care
 

Registration link: Click here hands icon purp